FXYD2 antisense oligonucleotide provides an efficient approach for long-lasting relief of chronic peripheral pain
Chronic pain, whether of inflammatory or neuropathic origin, affects about 18% of the population of developed countries, and most current treatments are only moderately effective and/or cause serious side effects. Therefore, the development of novel therapeutic approaches still represents a major ch...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical investigation
2023-05-01
|
| Серии: | JCI Insight |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1172/jci.insight.161246 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|